• Jeff
    link
    fedilink
    English
    arrow-up
    2
    ·
    1 year ago

    BIL has this as well so we also follow these articles and have been disappointed many times previously. Like you, I struggle between accepting that it’s a hard nut to crack VS big pharm being complacent in keeping a cash cow. We know big auto prefers to pay out for critical errors that kill an acceptable number of people vs fixing it if it’s more profitable so why not here too? I hate MBAs. They are the bane of the world.